IV + inhaled beta agonist vs inhaled beta‐agonist: Healthcare use: length of stay in the emergency department
IV + inhaled beta agonist showed no clear difference in length of stay in emergency department compared with inhaled beta‐agonist (moderate certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
IV + inhaled beta agonist vs inhaled beta‐agonist Length of stay in emergency department · patients with acute asthma IV + inhaled beta agonist showed no clear difference in length of stay in emergency department compared with inhaled beta‐agonist (moderate certainty). Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma (2012) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 46 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Addition of intravenous beta₂‐agonists to inhaled beta₂‐agonists for acute asthma 2012 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.